Ciprofibrate is a phenoxyacetic acid lipid-lowering drug, which is a new type of lipid-lowering drug.
Ciprofibrate competitively inhibits HMG-CoA reductase, reducing cholesterol synthesis; Increase the number of LDL receptors on the surface of hepatocytes, so that hepatocytes clear LDL cholesterol increased; Increase protease activity and increase very low-density lipoprotein clearance; Reduce blood viscosity, anticoagulant, antiplatelet aggregation, increase plasmin action, improve microcirculation.
|Apperance||White or almost white crystalline powder|
|Appearance:||White or almost white crystalline powder|
Guaranteed the purity
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!